Background. Follicular lymphoma is a common type of non-Hodgkin's lymphoma observed in Western countries. The diagnosis of this disease is based primarily on morphological and immunohistochemical assessment. The proliferative index Ki67 correlates with histological grading and clinical aggressiveness. Currently, positron emission tomography/computed tomography scanning are not applied for standard staging at diagnosis of follicular lymphoma and its use is limited to those patients for whom the identification of residual disease is crucial for therapeutic decisions and only when transformation to a high-grade lymphoma is suspected. Objectives. Our aim was to assess whether a correlation exists between the maximal standardized uptake value (SUVmax) at the biopsy site as detected via positron emission tomography/computed tomography and pathological (Ki67 and FL histological grade) and clinico-biological features (e.g. LDH, beta-2-microglobulin, Ann Arbor stage and FL International Prognostic Index -FLIPI) at diagnosis. Material and Methods. We retrospectively identified 16 patients during the previous 3.5 years in whom node biopsies were guided, taking into account the SUVmax as detected upon PET/CT scan at diagnosis. The results of these biopsies were diagnostic of follicular lymphoma. We also included 6 patients with high grade B cell lymphoma: 5 diffuse large B cell lymphoma (DLBCL) and 1 FL 3b histological grade. A 2-tailed non-parametric Spearman's correlation analysis of the SUVmax with Ki67, histological grade, LDH and b-2-microglobuline was performed. Results. The Ki67 (r = 0.73) and follicular lymphoma histological grade (r = 0.75) at the biopsy displayed a significant correlation with the SUVmax at diagnosis (p < 0.01). Conclusions. Our results suggest that SUV detected by positron emission tomography/computed tomography correlates with histological grade in follicular lymphoma/high grade B cell lymphoma, Ki67 and LDH. Positron emission tomography/computed tomography should be considered for guiding lymph node biopsy when transformation to a high-grade B cell lymphoma is suspected (Adv Clin Exp Med 2015, 24, 2, 325-330 ).
Follicular lymphoma (FL) is a common type of non-Hodgkin's lymphoma (NHL) observed in western countries. A recent review has indicated that FL was the most common low-grade lymphoma during the past 10 years worldwide [1] .
The diagnosis of this disease is based primarily on morphological and immunohistochemical assessment. The World Health Organization (WHO) defines FL as a neoplasm composed of follicle center (germinal center) B cells and classifies the disease as grades 1, 2, 3A, and 3B based on the number of centrocytes and centroblasts in the lymph node [2, 3] . The proliferative index Ki67 correlates with histological grading [4] and clinical aggressiveness. The analytical and clinical features of FL have been summarized in the FL International Prognostic Index (FLIPI) [5] ; however, no correlation with novel imaging techniques has been described.
Currently, positron emission tomography/ /computed tomography (PET/CT) scanning is not applied for standard staging at diagnosis of FL, although FL is a fludeoxyglucose (18F) ( 18 F-FDG)--avid disease and more than 90% of patients show PET/CT positivity at presentation [6] . Currently, the use of PET/CT in FL examination is limited to those patients for whom the identification of residual disease is crucial for therapeutic decisions and only when transformation to a high-grade lymphoma is suspected.
The main issues concerning FL treatment are the correct identification of patients with adverse prognosis who might benefit from more intensive treatment and the precise detection of cases in which transformation to a high-grade lymphoma is suspected.
It has been hypothesized that 18 F-FDG uptake reflects the proliferative activity of lymphoma cells and therefore is more intense in aggressive types of lymphoma. Some studies have reported a high diagnostic yield for 18 F-FDG-PET/CT, especially in patients with FL, while no diagnostic benefit has been observed with small lymphocytic lymphoma [7] .
Purpose
Our aim was to assess whether a correlation exists between the maximal standardized uptake value (SUVmax) at the biopsy site as detected via PET/CT and pathological (Ki67 and FL histological grade) and clinical-biological features (e.g., LDH, beta-2-microgloblin, Ann Arbor stage and FL International Prognostic Index -FLIPI) at diagnosis. We collected high grade B cell lymphoma data, which served as a control.
Methods
We retrospectively identified 16 patients during the previous 3.5 years in whom node biopsies were guided, taking into account the SUVmax as detected upon PET/CT scan at diagnosis. The results of these biopsies were diagnostic of FL. These PET/CT selected lymph nodes were processed as usual. Immunohistochemistry, Ki67 and histological grade were determined.
Data on clinical presentation, bone marrow infiltration, SUVmax at biopsy site, demographics, Ann Arbor stage, FLIPI results, laboratory parameters and histology, with grading parameters according to the current WHO classification, were collected. Staging with PET/CT was performed following the criteria published [8] .
As PET/CT has recently been introduced in our institution, this series is limited. Therefore, we included 6 patients with high grade B cell lymphoma: 5 diffuse large B cell lymphoma (DLBCL) and 1 FL 3b histological grade; this group works as a control of histological high proliferation tumor and strengthens the correlation analysis. The high grade B cell lymphoma patients were also included in the same way as the FL patients. It has been reported that DLBCL and transformed FL (or lowgrade lymphoma) display similar SUVs [9, 10] . This study followed the principles in the Declaration of Helsinki.
PET/CT Scan Procedure
The patient fasted for 6 h prior to 18 F-FDG PET/ /CT imaging, and blood glucose levels were measured prior to intravenous injection of 259 MBq (7 mCi) of 18F-FDG. Following tracer injection, the patient rested in a comfortable reclined position for 55 min. PET/ /CT imaging was initiated with a planar scout scan, to define the axial range of the study, followed by sequential volumetric CT and PET/CT acquisitions. Scanning was performed from the base of the skull down to the mid-thigh 60 min after 18 F-FDG injection using a Gemini TF PET/CT scanner (Philips Healthcare, Eindhoven, The Netherlands). The CT component consisted of a non-breath holding unenhanced 64-detector scan at 120 kVp, 50 mAs, and 5-mm slice width and separation. The PET/CT component consisted of a 3D time-of-flight (TOF) acquisition of 8 overlapping bed positions (2 min/bed position, 50% overlapping). Images were reconstructed with the software supplied using the reconstruction parameters recommended by the manufacturer, which consisted of an ordered subsets expectation maximization (OSEM) algorithm with 3 iterations and 33 subsets with incorporation of TOF information as well as attenuation, detector efficiency and normalization, scatter, and random coincidences to produce fully corrected images.
Standard descriptive analyses were carried out, and non-parametric correlation tests were calculated to assess the relationship between laboratory, pathological and clinical parameters. Two-tailed Spearman's non-parametric correlation analysis was performed between SUVmax and pathologic and clinical features. Correlation was considered relevant when r > 0 and statistically significant when p < 0.05. The analysis was performed using SPSS ver. 20 for MAC-OS.
Results
The patients' characteristics are summarized in Table 1 . Patients were categorized by histological grade to better visualize results. To be more exigent with the study, we performed a 2-tailed non-parametric Spearman's correlation analysis of the SUVmax with Ki67, histological grade (from lymph node biopsy guided by PET/CT), LDH and b-2-microglobuline (from patient at diagnosis). These results are summarized in Table 2 .
We found that Ki67 (r = 0.73) and FL histological grade (r = 0.75) at the biopsy site displayed a significant correlation with the SUVmax in the sampled lymph nodes at diagnosis (p < 0.01).
The results for the 1-tailed Spearman's correlation analysis of the SUVmax during lymph node biopsy and the Ki67, histological grade, 
Discussion
Currently, CT scanning is considered the standard for FL staging. However, CT only takes into account the size of the lymph nodes but not the metabolic state associated with the disease. Since the introduction of PET/CT, several studies have evaluated the sensitivity of the technique both in Hodgkin's and non-Hodgkin lymphomas [11, 12] . Recently, data obtained from the FOLL5 trial have been published regarding the impact of using PET/CT instead of CT scans for FL staging [13] . PET/CT identified a higher number of nodal areas in 32% of patients and more extranodal sites than CT scans; therefore, the FLIPI was also affected when using PET/CT scanning. In the PRIMA study, the use of PET/CT status at the end of treatment, but not the conventional response, was an independent predictive factor of lymphoma progression [14] .
In the present study, we sought to investigate whether a correlation exists between the SUVmax at the biopsy site, as detected via PET/CT at diagnosis and pathological and clinical-biological features. This was carried out because PET scanning is a functional imaging technique that allows for the visualization and quantification of glucose metabolism.
FL histological grading depends on the proportion of centrocytes to centroblasts, ranging from grade 1 FL, which is comprised of low numbers of centroblasts (0-5 per high-power field), to grade 3b FL, which is marked by solid sheets of large B cells. FL histological grading has not been assessed with different clinical prognosis, with the exception of 3b in adults. Furthermore, 3b FL exhibits many molecular characteristics similar to DLBCL, possibly explaining the associated divergent prognosis [15] . Therefore, the proper diagnosis of this subgroup of FL is clinically relevant because it affects treatment. In fact, evidence of clonal evolution inside of distinct histological grades has been reported [16] . This observation renders the coexistence of various histological grades in one patient possible. Moreover, this is also true for the transformation of a low-grade lymphoma into a high-grade lymphoma. Clinicians usually have some difficulty in assessing this transformation due to the poor performance status of patients during relapse and in older-aged patients; these difficulties commonly prevent biopsies. Since DLBLC and FL represent almost 50% of our new lymphoma cases, then PET/CT might be useful for proper guidance for biopsy at staging. Its role in the evaluation during and after treatment should be analyzed in large series. On the other hand, we cannot forget that PET/CT also exposes the patient to more radiation, and for this reason its use should be carefully studied.
In our study, we found that SUVmax node biopsy guidance correlated with almost all of the pathological and clinical parameters that are commonly applied.
Due to the transcendence of FL histological grade in the selection of initial treatment, the most relevant finding of our study was the correlation between SUVmax and histological grade. Spearman's coefficient (r = 0.75) revealed a linear dependence between both variables (Fig. 1) . This finding may be useful for biopsy guidance.
Moreover, when transformation is suspected, the correlation between SUVmax and Ki67 (r = 0.73) is important, as a higher than expected SUVmax readout in a diagnosed low-grade lymphoma may suggest transformation.
Our results suggest that SUV detected by PET/CT correlated with histological grade in follicular lymphoma/high grade B cell lymphoma, Ki67 and LDH. PET/CT should be considered for guiding lymph node biopsy when transformation to a high-grade B cell lymphoma is suspected. These findings may contribute to further use of PET/CT at diagnosis when suspecting a B cell lymphoma. 
